Stage IIA Prostate Cancer AJCC v8
18
1
10
2
Key Insights
Highlights
Success Rate
40% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
16.7%
3 terminated out of 18 trials
40.0%
-46.5% vs benchmark
6%
1 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (18)
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer
Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners
RElugolix VErsus LeUprolide Cardiac Trial
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy
Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer